Li N - Search Results

1

Li N, Fan X, Wang X, Deng H, Zhang K, Zhang X, Han Q, Lv Y, Liu Z. Li N, et al. Immunol Invest. 2019 May;48(4):378-391. doi: 10.1080/08820139.2019.1567532. Epub 2019 Mar 25. Immunol Invest. 2019. PMID: 30907204

2

PD-1 mRNA expression is associated with clinical and viral profile and PD1 3'-untranslated region polymorphism in patients with chronic HBV infection.

Zhang G, Li N, Zhang P, Li F, Yang C, Zhu Q, Han Q, Lv Y, Zhou Z, Liu Z. Zhang G, et al. Among authors: li f, li n. Immunol Lett. 2014 Nov;162(1 Pt A):212-6. doi: 10.1016/j.imlet.2014.09.001. Epub 2014 Sep 9. Immunol Lett. 2014. PMID: 25218665

3

Association between TNFAIP3 nonsynonymous single-nucleotide polymorphism rs2230926 and chronic hepatitis B virus infection in a Chinese Han population.

Zhang P, Li N, Zhu Q, Li F, Yang C, Zeng X, Lv Y, Zhou Z, Han Q, Liu Z. Zhang P, et al. Among authors: li f, li n. Virol J. 2015 Feb 28;12:33. doi: 10.1186/s12985-015-0268-6. Virol J. 2015. PMID: 25890346 Free PMC article.

4

Association of PTPN22 gene polymorphisms with chronic hepatitis B virus infection in Chinese Han population.

Li F, Li N, Zhu Q, Zhou Z, Zhang P, Yang C, Han Q, Lv Y, Wei P, Liu Z. Li F, et al. Among authors: li n. Hum Immunol. 2015 Oct;76(10):736-41. doi: 10.1016/j.humimm.2015.09.030. Epub 2015 Sep 30. Hum Immunol. 2015. PMID: 26429315

5

Elevated serum soluble CD14 levels in chronic HBV infection are significantly associated with HBV-related hepatocellular carcinoma.

Li N, Zhu Q, Yang C, Li F, Zhou Z, Lv Y, Sang J, Han Q, Liu Z. Li N, et al. Among authors: li f. Tumour Biol. 2016 May;37(5):6607-17. doi: 10.1007/s13277-015-4423-x. Epub 2015 Dec 7. Tumour Biol. 2016. PMID: 26643893

6

Differential association of STAT3 and HK-II expression in hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma.

Li M, Wang W, Jin R, Zhang T, Li N, Han Q, Wei P, Liu Z. Li M, et al. Among authors: li n. J Med Virol. 2016 Sep;88(9):1552-9. doi: 10.1002/jmv.24498. Epub 2016 Mar 8. J Med Virol. 2016. PMID: 26889748

7

Genetic polymorphisms of immune checkpoint proteins PD-1 and TIM-3 are associated with survival of patients with hepatitis B virus-related hepatocellular carcinoma.

Li Z, Li N, Li F, Zhou Z, Sang J, Jin Z, Liu H, Han Q, Lv Y, Liu Z. Li Z, et al. Among authors: li f, li n. Oncotarget. 2016 May 3;7(18):26168-80. doi: 10.18632/oncotarget.8435. Oncotarget. 2016. PMID: 27034168 Free PMC article.

8

Immune checkpoint proteins PD-1 and TIM-3 are both highly expressed in liver tissues and correlate with their gene polymorphisms in patients with HBV-related hepatocellular carcinoma.

Li Z, Li N, Li F, Zhou Z, Sang J, Chen Y, Han Q, Lv Y, Liu Z. Li Z, et al. Among authors: li f, li n. Medicine (Baltimore). 2016 Dec;95(52):e5749. doi: 10.1097/MD.0000000000005749. Medicine (Baltimore). 2016. PMID: 28033288 Free PMC article.

9

Circulating soluble programmed death-1 levels may differentiate immune-tolerant phase from other phases and hepatocellular carcinoma from other clinical diseases in chronic hepatitis B virus infection.

Li N, Zhou Z, Li F, Sang J, Han Q, Lv Y, Zhao W, Li C, Liu Z. Li N, et al. Among authors: li f, li c. Oncotarget. 2017 Jul 11;8(28):46020-46033. doi: 10.18632/oncotarget.17546. Oncotarget. 2017. PMID: 28545019 Free PMC article.

10

Association of LTBR polymorphisms with chronic hepatitis B virus infection and hepatitis B virus-related hepatocellular carcinoma.

Zhu Q, Li N, Li F, Sang J, Deng H, Han Q, Lv Y, Li C, Liu Z. Zhu Q, et al. Among authors: li f, li c, li n. Int Immunopharmacol. 2017 Aug;49:126-131. doi: 10.1016/j.intimp.2017.05.031. Epub 2017 May 30. Int Immunopharmacol. 2017. PMID: 28575727

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,367 results

Search Page

Filters